Asymchem Laboratories (HKG:6821, SHE:002821) slashed the repurchase price for first grants under a 2025 China-listed share scheme to 36.42 yuan per share from 37.52 yuan apiece, respectively, a Dec. 19 Hong Kong bourse filing said.
Shares of the pharmaceutical outsourcing services firm were down nearly 3% in Monday afternoon trading
The move came after the firm distributed a cash dividend of 11 yuan under a 2024 buyback plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments